LifeMD is trading 9.5% up in pre-market at $3.00 on October 5, 2026, versus its October 2 close of $2.74, with no confirmed company-specific announcement explaining the move.

  • The available Q2 earnings-call transcript is dated August 5 and does not explain the October 5 share move.
  • Major U.S. indices were modestly lower pre-market; the supplied market context does not establish a broad-market explanation for LifeMD’s gain.